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Video-assisted thoracic surgical techniques are widely used for biopsy and 
resection of thoracic tumors, but studies of long-term outcomes have not 
been reported. Dissemination of tumor by these techniques is a potential 
hazard. Therefore we surveyed the surgical members of the Video-Assisted 
Thoracic Surgery Study Group to determine whether tumor implants 
thought to be directly related to video-assisted techniques had occurred. 
Surgeons reported 21 cases. The sites of recurrence were the incision (n = 
14), pulmonary staple line (n  = 2), pleura (n = 2), both staple line and 
incision (n = 1), both pleura and incision (n = 1), and both pleura and 
staple line (n = 1). Review of these cases illustrates the pitfalls of present 
video-assisted techniques for malignant tumors of the thorax. (J Thorac 
Cardiovasc Surg 1996;111:954160) 
A fter the introduction of video-assisted thoracic surgery (VATS) in late 1980s, physicians, sur- 
geons, and patients rapidly adopted the technique 
for biopsy and, occasionally, for curative resection of 
malignant tumors of the thorax. Despite the attrac- 
tiveness of this approach, little long-term informa- 
tion exists to validate its widespread adoption. 
One limitation of the VATS technique is that 
tumors are often visualized only as a distortion of 
the visceral or parietal surface and are palpable only 
with the fingertips. This limited ability to clearly 
define tissue margins has raised concerns that VATS 
techniques may be more likely to disrupt and dis- 
seminate malignant tumors than the type of manip- 
ulation that occurs during an open thoracotomy.1 A 
recent case report described the implantation of a 
malignant tumor within chest wall incisions during a 
seemingly uneventful and complete resection of a 
single nodule of metastatic adenocarcinoma. 2 Sub- 
sequently, to determine whether other general tho- 
racic surgeons skilled in VATS techniques have 
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encountered this potentially serious problem, we 
surveyed 55 members of the Video-Assisted Tho- 
racic Surgery Study Group (VATSSG). Surgeons 
were asked to submit any cases in which the manner 
of recurrence of malignant disease suggested is- 
semination of the tumor at the time of a VATS 
procedure. 
Methods 
The VATSSG is composed of surgeons whose practices 
include at least 50% general thoracic surgery. 3 Contact 
with the members was by either telephone or mail. All 
positive responses were confirmed in writing. The ques- 
tionnaire began: "Have you participated in the care of any 
patient who underwent a VATS procedure for the biopsy 
or resection of a thoracic malignancy and whose subse- 
quent course suggests either subcutaneous implantation, 
pleural seeding, or staple-line recurrence of the malignan- 
cy?" If this question was answered affirmatively, further 
data were solicited: the date of the thoracoscopic proce- 
dure, the preoperative diagnosis, the type of procedure, 
the use of adjuncts to localize the nodule, the use of 
techniques to isolate the surgical specimen from the 
subcutaneous tissues, the histologic diagnosis, and any 
surgical procedures, uch as thoracotomy and lobectomy, 
that were done after the wedge biopsy. Also, information 
on the date of diagnosis of the recurrence, the symptoms 
of recurrence, and the location, treatment, and outcome 
of the recurrence were collected. 
Results 
Forty-eight of 55 surgeons (87%) replied to in- 
quiries. Sixteen surgeons reported a total of 21 cases 
that fit the pattern of tumor progression or recur- 
rence suggesting dissemination of malignant disease 
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Table I. Primary lung cancers 
Time to 
Histologic Site of  recurrence 
type recurrence (mo) Outcome 
Adenocarcinoma Pleura/incision 3 Alive 
Adenocarcinoma Incision 18 Alive 
Adenocarcinoma Pleura 4 Dead 
Adenocarcinoma Incision 3 Dead 
Adenocarcinoma Incision 11 Dead 
Adenocarcinoma Incision 23 Dead 
Squamous Suture line 12 Alive 
Squamous Suture line 14 Alive 
Squamous Incision 4 Dead 
Table II. Disease metastatic to lung 
Time to 
Histologic Site of recurrence 
type recurrence (too) Outcome 
Spindle cell sarcoma Suture line and 2 Alive 
incision 
Uterus Suture line and 4 Alive 
pleura 
Medullary thyroid Incision 8 Alive 
Melanoma Pleura 6 Alive 
Colon adenocarcinoma Incision 1 Alive 
at the time of thoracoscopy. One surgeon, after 
completing a questionnaire, published the material 
as a detailed case report4; this case is included in this 
report. 
The histologic haracteristics, site of recurrence, 
time to recurrence, and outcome at the time of the 
surgeon's report are summarized in Tables I to IV. 
The initial operations were performed between 
June 1987 and February 1994. The time from the 
original thoracoscopic procedure to diagnosis of 
recurrence ranged from 2 weeks to 29 months 
(mean 7.6 months, median 4 months). 
Aids to locate tumors at the time of the initial 
operation included preoperative needle localization 
(n = 1), digital palpation (n = 4), none (n = 9), and 
not reported (n = 7). Techniques to isolate tissue 
removed from contact with the subcutaneous tis- 
sues, such as disposable ports or bags, were used in 
seven patients, not used in nine, and not reported in 
five. In the procedures in which the preoperative 
diagnosis was either an indeterminate nodule (n = 
12) or a known primary lung tumor (n = 1), eleven 
reports stated that the procedure was not converted 
to an open thoracotomy and lobectomy, and two 
reports gave no information. The preoperative di- 
agnoses in the eight other cases were mediastinal 
masses (n = 2) or pleural effusions (n = 6). 
Table Ill. Mesotheliomas 
Site of  Time to 
recurrence recurrence (too) Outcome 
Incision 2 Dead 
Incision 2 Alive 
Incision 29 Alive 
Incision 0.5 Alive 
Incision 1 Alive 
Table IV. Other histologic types 
Time to 
Histologic Site of recurrence 
type recurrence (too) Outcome 
Small-cell carcinoma Incision 8 Alive 
of lung 
Esophageal squamous Incision 4 Alive 
carcinoma 
Recurrence was first suspected on the basis of a 
painless subcutaneous mass in eleven patients, a 
subcutaneous mass and effusion in one, a painful 
subcutaneous mass in four, dyspnea in one, and an 
asymptomatic radiologic finding in four. Treatments 
to control recurrence included resection in five, 
resection and radiotherapy in two, resection and 
chemotherapy in two, chemotherapy in two, pleu- 
rodesis in two, radiotherapy in three, radiotherapy 
and chemotherapy in one, and supportive care 
alone in one; this information was not reported in 
three. 
Representative case reports 
CASE 1. In early 1992, as part of a routine physical 
examination, a 62-year-old retired sheet metal 
worker had a chest radiograph and computed tomo- 
gram (Fig. 1), which showed a mass in the right lung. 
Bronchoscopic washings demonstrated cells consis- 
tent with squamous cell carcinoma. Results of the 
preoperative evaluation were all within normal im- 
its, including physical examination, pulmonary func- 
tion tests, arterial blood gas values with the patient 
breathing room air, bone scan, and computed tomo- 
grams of the brain. No evidence of metastatic 
disease was detected. Mediastinoscopic examination 
revealed no abnormalities. The patient underwent a 
resection of the posterior portion of the anterior 
segment of the right upper lobe by means of VATS 
techniques. The mass was removed through an 
incision in the right fifth intercostal space in the 
anterior axillary line. The pathologic diagnosis was 
"moderately poorly differentiated squamous carci- 
noma" which "approximates but does not infiltrate 
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Fig. 1. Preoperative thoracic computed tomogram dem- 
onstrating a mass in the peripheral right midlung field. No 
pleural effusion or adenopathy noted. 
the pleural surface." The parenchyma atthe stapled 
margin did not involve tumor. 
The initial recovery was uneventful. However, dur- 
ing the fourth postoperative month, complaints of 
persistent pain in the anterior chest wall led to 
computed tomograms of the chest (Fig. 2), which 
demonstrated a 3 cm mass in the region of the 
anterior incision and a pleural effusion. Information 
regarding the cytologic haracteristics of the effu- 
sion is not available. The chest wall was excised, 
including portions of two ribs and the tract. Patho- 
logic examination located three nodules of squa- 
mous cell carcinoma: one in the intercostal soft 
tissue and two in the subcutaneous ti sues, sugges- 
tive of metastases from the primary lung tumor. 
Postoperative radiotherapy was given to the right 
anterior chest wall. Nevertheless, by the eighth 
postoperative month, physical examination and 
chest computed tomograms (Fig. 3) showed arecur- 
rent soft tissue mass medial and anterior to the area 
of chest wall resection, as well as probable spread 
within the lung parenchyma and the pleural space. 
Because of the extensive operation necessary to 
resect the mass and the deteriorating respiratory 
reserve of the patient, the risk of resection for cure 
was prohibitive. Chemotherapy (mitomycin/cispla- 
tin/vinblastine) was initiated. 
CASE 2. A 38-year-old woman who received man- 
tle irradiation for stage IA Hodgkin's disease in 
1979 noted the development of a chronic cough in 
late 1993. Chest radiographs and computed tomo- 
grams demonstrated multiple bilateral lung paren- 
chymal nodules. VATS was performed on the right 
side with wedge excision of two nodules from the 
right upper lobe and one from the right lower lobe 
of the lung and a pleural biopsy. The pathology 
report was "spindle and round cell sarcoma in 
several foci" consistent with metastatic spread 
from an unknown primary tumor. Further evalu- 
ation revealed a sarcoma of the left leg. Within 8 
weeks of thoracoscopic resection, a massive recur- 
rence developed around the staple line and in the 
chest wall (Fig. 4). Reoperation i cluding a right 
upper lobectomy and partial chest wall resection 
was performed. 
CASE 3. A new right lung mass developed in a 
68-year-old woman (Fig. 5) 2 years after esection of 
a colon adenocarcinoma. Thoracoscopic wedge ex- 
cision of the lung nodule revealed metastatic ade- 
nocarcinoma consistent with a primary tumor of the 
colon. Eight months after the thoracoscopic proce- 
dure, partial resection f the right chest wall re- 
vealed adenocarcinoma, histologically identical to 
the lung tumor, eroding a rib under the thoracos- 
copy incision (Fig. 6). 
Discussion 
Until now, local dissemination and implantation 
of most malignant tumors f the thorax to thoracot- 
omy incisions have been infrequent. Only mesothe- 
lioma invades incisions, pleural biopsy sites, or chest 
tube insertion sites with any frequency, s Implanta- 
tion of other histologic types of thoracic tumors is 
rare. Although case reports have been published of 
implantation metastasis a  a result of needle biopsy 
of other histologic types of lung tumors, 6'7 the risk is 
low. In one report, only one case occurred in 1264 
positive biopsy results over a period of 14 years) 
Intraoperative pleural washings obtained after pul- 
monary resections through a thoracotomy incision 
suggest that microscopic spillage of tumor cells does 
occur, most commonly during the lysis of tumor 
adhesions to the parietal pleural surface. 9'1° Al- 
though no reports have been published of small 
primary or secondary malignant lung tumors being 
implanted in a thoracotomy incision after lung re- 
section, larger intrathoracic malignant tumors would 
seem to be at greater isk for the implantation of 
malignant tissue. For example, spillage of tumor 
cells probably occurs during resections of esopha- 
geal tumors because of the narrow margins afforded 
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Fig. 2. Thoracic omputed tomogram obtained 4 months after the operation, demonstrating a 3 cm mass 
under the right pectoralis major muscle in the region of the anterior thoracoscopy incision. An 
uncharacterized pleural effusion is present. 
Fig. 3. Thoracic computed tomogram obtained 4 mouths after partial chest wall resection of recurrent 
tumor in the anterior thoracoscopy incision demonstrates second recurrence inthe right anterior chest wall 
in the region between the prior chest wall resection and the sternum. 
by the proximity of the aorta and the vertebral 
column. However, chest wall implants after esoph- 
agectomy for malignant disease are reported only 
rarely.ll, 12 
Mediastinoscopic biopsy of lymph nodes involved 
with metastatic disease often disrupts the node 
capsule. Despite isolated case reports of tumor 
growing within mediastinal incisions, 13' 14 a review 
by Aushbaugh 15 reported mediastinoscopic tumor 
implantation in only eight of 6490 procedures 
(0.1%). There are factors that may reduce the 
likelihood of incision implantation during mediasti- 
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Fig. 4. Computed thoracic tomogram demonstrating re- 
currence of a sarcoma metastatic to the lung 8 weeks after 
thoracoscopic resection. 
noscopy. Specimens are removed through the pro- 
tective passage of the mediastinoscope, radiation 
may be given to the mediastinum, and the limited 
life expectancy of patients with disseminated lung 
cancer may limit the period during which implants 
could become apparent. 
This report describes 21 cases in which thoracic 
malignant disease recurred along the margin of 
resection, on the pleural surface, or within the chest 
wall after VATS procedures. It is not intended to be 
an exhaustive r cording of all of the potential cases 
of tumor implantations from VATS procedures over 
a 7-year period but rather a chronicling of some 
representative suggestive cases from surgeons expe- 
rienced in VATS techniques. In fact, this was a 
voluntary reporting based on recollection and 
should be considered a collection of anecdotes. The 
denominator f the number of thoracoscopic proce- 
dures from which these cases are drawn is unknown. 
The total number of procedures performed by the 
members of the VATSSG is unknown. Some of the 
procedures reported were not performed by mem- 
bers of the VATSSG; the operations were per- 
formed by other surgeons at the same institution or 
else the patients were referred for postoperative 
consultation from other institutions. Finally, the 
burden for defining the recurrence as a consequence 
of intraoperative events was placed on the operating 
surgeon, a fact that would lead to a conservative 
report. 
Some of the cases presented might not be consid- 
ered complications of the VATS technique. Five 
cases involve mesothelioma. Because the propensity 
for such tumors to grow into thoracotomy and chest 
tube incisions is widely recognized, mesotheliomas 
should be considered separately from the other 
cases. Of the histologic types ncountered, small- 
cell carcinoma of the lung and melanoma re ag- 
gressive nough that implantation can be expected. 
The preoperative diagnosis in one other case was 
pleural effusion (subsequently diagnosed as pulmo- 
nary adenocarcinoma), and it is possible that tumor- 
laden fluid led to implantation i the thoracoscopy 
track. The remaining 13 cases are difficult to con- 
sider as complications tobe expected after thoracic 
surgery. Furthermore, the interval between thora- 
coscopy and diagnosis of recurrence is sufficiently 
short to suggest a large inoculum of tumor cells, 
consistent with tumor disruption. 
The thoracic medical and surgical community 
embraced VATS because of the rapid recuperation 
experienced by most patients. This is one of the 
phases that any new technique must go through. The 
second phase is recognition of the limitations of the 
technique with later appropriate application] 6 
However, a surgeon who is accustomed to perform- 
ing lung resections through a thoracotomy may feel 
at a disadvantage when performing lung resections 
with VATS techniques. Current imaging techniques 
allow the operating surgeon to see only the visceral 
and parietal pleural surfaces of the thoracic avity, 
with palpation of tissues limited to what can be 
reached by fingertips inserted between ribs. Ultra- 
sonography has been advocated as an aid to image 
structures within the lung and mediastinal tissues, 17 
but for technical reasons it is unlikely that the 
images obtained will approach the sensitivity of 
direct bimanual palpation of the lung. To date, it is 
not clear whether the technical limitations f VATS 
technology will lead to an increased risk of suture- 
line recurrences or pleural or chest wall implants, 
because the available literature is limited to fol- 
low-up periods of 30 days only. 
The technical problems that may be responsible 
for disruption of tumor appear to be twofold. First, 
pulling the tumor mass through relatively small 
incisions may deposit dumps of viable tumor cells in 
the chest wall. It is also possible that pleural implan- 
tation could result from attempts o pull a large 
mass through a small chest incision. Similar con- 
cerns have been voiced after observing seeding of 
laparoscopic surgical sites involving gall bladder 
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Fig. 5. Preoperative computed tomogram demonstrating a colon carcinoma metastatic to the right lung. 
Fig. 6. Computed tomogram obtained 8 months after VATS resection of a metastatic colon carcinoma, 
demonstrating a right chest wall recurrence eroding a rib under a thoracoscopy ort site. 
carcinoma,iS, 19 hepatocellular carcinoma, 2° gastric 
adenocarcinoma, 21 and trophoblastic tissue 22 and, 
most disturbingly, after laparoscopic colectomy for 
colonic adenocarcinoma. 23 It has been suggested 
that specimens be placed within surgical gloves or 
special bags before extraction to protect against 
chest wall implantation during VATS procedures. 1 
Much as the mediastinoscope may offer some pro- 
tection against implantation during the biopsy of 
involved mediastinal lymph nodes, removing un- 
characterized small biopsy specimens through plas- 
tic or metal ports inserted into the chest wall 
incisions may reduce the risk of seeding, but this has 
not been proved. 
The cases in this report suggest hat the more 
intractable problem may be disruption of the tumor 
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at the t ime of removal from the lung parenchyma, 
leading to implantat ion either along the margin of 
resection or on the pleural surface. Pleural washing 
studies 9,lo performed during thoracotomy suggest 
that malignant cells are released into the pleural 
space during pulmonary resection. However, the 
fact that pleural  or chest wall implants are rare after 
thoracotomy suggests that such microscopic deposits 
may be only marginally viable and may have little or 
no contact with the subcutaneous tissues. Current 
thoracoscopic techniques may lead to the deposition 
of larger, more viable clumps of tissue. 
Critics of thoracoscopic techniques have already argued 
that thoracoscopic wedge excision of a lung cancer is an 
inadequate cancer operation and, should a malignant 
tumor be diagnosed uring thoracoscopy, a thoracotomy 
and 10bectomy should be performed. This recommenda- 
tion is based on the multicenter t ial of the Lung Cancer 
Study Group, which demonstrated that local recurrence 
was mote frequent after wedge or segmental resection of 
stage I luiig cancers. 24 Before the widespread adoption of 
VATS procedures for the curative resection of intratho- 
racic malignant tumors, reports of long-term outcomes 
are needed. 
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